Loading market dashboard
Oncternal Therapeutics, Inc.
ONCTHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Oncternal Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2028 | $1.00M | $1.00M - $1.00M | -$600.0K | -$4.77 | 1 |
| Dec 2027 | $1.00M | $1.00M - $1.00M | -$600.0K | -$6.79 | 1 |
| Dec 2026 | $1.00M | $1.00M - $1.00M | -$600.0K | -$6.16 | 1 |
| Dec 2025 | $600.0K | $600.0K - $600.0K | -$360.0K | -$10.25 | 1 |
| Dec 2024 | $1.92M | $1.92M - $1.92M | -$1.15M | -$12.43 | 1 |
| Dec 2023 | $1.85M | $1.85M - $1.85M | -$1.11M | -$12.176 | 1 |
| Dec 2022 | $1.60M | $1.60M - $1.60M | -$960.3K | -$16.913 | 1 |
| Dec 2021 | $4.82M | $4.54M - $5.10M | -$2.89M | -$14.32 | 2 |
| Dec 2020 | $2.37M | $2.24M - $2.51M | -$1.42M | -$19.80 | 2 |
| Dec 2012 | $3.24M | $2.59M - $3.88M | -$52.70M | -$8.215 | 10 |
| Dec 2011 | $19.11M | $15.29M - $22.93M | -$33.28M | -$7.305 | 15 |
| Dec 2010 | $58.24M | $46.59M - $69.89M | $17.51M | $4.36 | 11 |